# Prograf-Advagraf Cross Over Conversion Study

> **NCT01797341** · PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 13 (actual)

## Conditions studied

- Kidney-Pancreas Transplantation

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT01797341
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797341, "Prograf-Advagraf Cross Over Conversion Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01797341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*